Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd. on August 30, 2018. The filing reports on a corporate governance event: an Extraordinary Meeting of Shareholders convened on the filing date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notice of a shareholder meeting and contains no financial statements or performance data.
Material Changes
The primary material event reported is the adjournment of the Extraordinary Meeting of Shareholders held on August 30, 2018, due to a lack of quorum. No financial changes or operational updates were disclosed in this specific filing.
Outlook and Management Commentary
Management has scheduled a reconvened Extraordinary Meeting of Shareholders for Thursday, September 6, 2018, at 11:00 a.m. (Israel time). The meeting will be held at the offices of the Company's legal counsel, Doron, Tikotzky, Kantor, Gutman & Amit Gross, located at B.S.R 4 Tower, 33rd Floor, 7 Metsada Street, Bnei Brak. The filing does not contain specific guidance, risk factors, or commentary on unusual items beyond the meeting logistics.
Key Facts for Investor Verification
- The original shareholder meeting on August 30, 2018, failed to achieve a quorum.
- A new meeting date is set for September 6, 2018, at the same time and location.
- This filing contains no financial data; investors should refer to the Company's Form 20-F for financial performance.
- The filing was signed by Eyal Leibovitz, Chief Financial Officer.